FRCA Notes


Traumatic Major Haemorrhage


  • Haemorrhage causes around 40% of trauma deaths in the UK and most occur within 3-6 hours of injury
  • It is the leading cause of potentially preventable trauma death
  • Management has moved from large-volume crystalloid resuscitation to damage control resuscitation, with improved survival
  • Haemorrhagic shock is a surgical emergency: resuscitation buys time for haemorrhage control, it does not replace it


Definitions of major haemorrhage
Loss of one circulating volume in 24 hours
Loss of 50% of circulating volume within 3 hours
Blood loss >150 ml/min
Bleeding causing SBP <90 mmHg or heart rate >110 bpm
SBP <90 mmHg despite 4 units of red cells within 60 minutes, with no other cause

  • Massive transfusion is often defined as ≥10 units of red cells in 24 hours
  • 'Major haemorrhage protocol' is the preferred term, as the aim is to prevent the need for massive transfusion

Limitations of clinical assessment

  • Blood pressure is a poor surrogate of flow as sympathetic compensation can maintain BP despite significant loss, particularly in the young
  • Older patients and those on beta-blockers may not mount a tachycardia ± paradoxical bradycardia can occur in major haemorrhage
  • Pulses are lost (radial, then femoral, then carotid) at lower pressures than ATLS teaching suggests
  • Haemoglobin is a concentration, not a volume: a normal value in acute bleeding is falsely reassuring
  • Base deficit and lactate are more sensitive markers of hypoperfusion; serial trends are more useful than single values

Imaging

  • Whole-body CT is the imaging of choice and improves survival in blunt trauma, should aim for CT within 30 minutes of arrival
  • FAST: rapid 'cavity triage' for free fluid and pericardial collection although must not delay treatment or transfer
  • The unstable patient with a positive FAST may go straight to theatre or IR, although in modern trauma centres CT may still be appropriate if it is close and fast
  • Chest and pelvic X-rays may be considered for patients too unstable for CT, to identify immediately life-threatening sources

  • Damage control resuscitationaims to maintain vital organ perfusion without worsening bleeding or coagulopathy, until definitive haemostasis
  • It begins prehospitally and continues through the ED, theatre and ICU
  • It follows a C-ABC paradigm, where catastrophic haemorrhage control takes priority over airway management
  • Early haemorrhage control is a must e.g. direct pressure, tourniquets, haemostatic dressings, pelvic binder, long bone traction
  • Its core principles are:
    1. Permissive hypotension
    2. Haemostatic resuscitation i.e. blood products as the primary resuscitation fluid, tranexamic acid, correction of hypothermia and hypocalcaemia
    3. Damage control surgery i.e. rapid transfer for definitive haemostasis by surgery or interventional radiology

1 - Permissive hypotension

  • Restricting fluid to accept a lower than normal blood pressure until bleeding is controlled
  • Rationale: higher pressure may disrupt clot formation, and fluid dilutes clotting factors and causes hypothermia

  • Targets vary although SBP 70-90mmHg or a palpable radial pulse are reasonable

  • Issues and contraindications
    • Most of the evidence is from penetrating trauma cases where there was no neurological injury
    • Should not be prolonged e.g. novel hybrid resuscitation allows permissive hypotension for maximum 60mins
    • Even brief periods of hypotension worses outcome after TBI; use higher targets
    • Not suitable in some other cohorts too e.g. spinal cord injury, patients with impaired autoregulation e.g. elderly
    • Must exlcude causes of hypotension e.g. tension pneumoathorax and not presume hypotension is due to haemorrhage alone

2 - Haemostatic resuscitation

  • Using blood products as the primary resuscitation fluid, effectively giving whole blood in its component parts
  • NICE recommends a red cell to plasma ratio of 1:1 in actively bleeding trauma patients
  • Plasma:platelet:red cell ratios of 1:1:1 vs. 1:1:2 showed no difference in 30-day mortality, but fewer deaths from exsanguination at 24 hours with 1:1:1 (PROPPR, 2015)
  • Platelets and fibrinogen replacement (cryoprecipitate or fibrinogen concentrate) follow, either by protocol or guided by testing
  • Protocolised packs should give way to goal-directed therapy as soon as results allow, as over-transfusion carries its own morbidity

3 - Damage control surgery

  • An abbreviated operation to control haemorrhage and contamination, prioritising physiology over anatomical repair
  • Three phases:
    1. Initial surgery (ideally <90 minutes): packing, shunts, ligation, temporary abdominal closure
    2. ICU resuscitation: rewarming, correction of coagulopathy and acidosis
    3. Planned definitive surgery once physiology is restored

Triggers for damage control surgery
Persistent haemodynamic instability despite resuscitation
pH <7.2 or lactate >5 mmol/L
Hypothermia (<35°C; severe if ≤33°C)
Coagulopathy (clinical or laboratory)
>10 units of red cells transfused or estimated blood loss >5 L
Injury pattern: major abdominal vascular injury, multicavity haemorrhage, need for resuscitative thoracotomy

Interventional radiology

  • Embolisation or stent-grafting is a less invasive alternative to surgery, sparing the physiological insult of laparotomy
  • Indications include:
    • Transient responders with solid organ (liver, spleen, kidney) injury
    • Unstable pelvic fracture with arterial bleeding and no other life-threatening injury
    • Stable great vessel injury
  • Surgery remains the gold standard for multifocal haemorrhage and critical instability
  • The IR suite is often remote which carries its own challenges; hybrid theatres can circumvent this


Fluid Key considerations
Crystalloid Dilutional coagulopathy and anaemia
Hypothermia if not warmed
0.9% saline contributes to acidosis
Balanced solutions improve acid-base status but not mortality
Hypertonic solutions have no proven benefit
Colloid No mortality benefit
Increase risk of nephrotoxicity, coagulopathy and anaphylaxis
4% albumin increased mortality in severe TBI
Red cells Prehospital red cells alone are safe
Mortality benefit is only seen when combined with plasma
Plasma Prehospital plasma reduced 30-day mortality compared with standard care (PAMPer, 2018)
Whole blood Used in the military
Retrospective data suggest benefit but meta-analysis shows no 24-hour or 30-day mortality benefit



Factor Target Intervention
Haemoglobin 70-90 g/L Red cells
Platelets >50 × 109/L (>100 × 109/L in TBI) Platelet transfusion
Fibrinogen >1.5 g/L Cryoprecipitate or fibrinogen concentrate
PT and APTT <1.5 × normal FFP; PCC if anticoagulated
Ionised calcium 1.1-1.3 mmol/L 10 ml 10% calcium chloride
Potassium 3.5-5.0 mmol/L Insulin and dextrose for hyperkalaemia
Temperature >36°C Warmed fluids, forced-air warming
pH and lactate pH >7.2; lactate <4 mmol/L and falling Haemorrhage control and resuscitation

  • Local protocols may vary
  • The primary importance of calcium replacement is cardiac contractility rather than coagulation; give empirically according to volume transfused until blood gas results are available
  • Avoid bicarbonate where possible as it masks base deficit and lactate as markers of resuscitation

Conventional coagulation tests

  • PT, APTT, Clauss fibrinogen and platelet count are widely available
  • They are relatively insensitive to trauma-induced coagulopathy, are performed at 37°C and take too long to guide rapid transfusion

Viscoelastic haemostatic assays (TEG and ROTEM)

  • Point-of-care, real-time assessment of clot initiation, strength and lysis, and of the relative contributions of fibrinogen and platelets
  • Typical findings in trauma-induced coagulopathy:
    • Prolonged reaction or clotting time: delayed clot initiation (give FFP)
    • Reduced maximum amplitude or clot firmness: weak clot (platelets or fibrinogen)
    • Low functional fibrinogen: give cryoprecipitate
    • Increased lysis (e.g. LY30): hyperfibrinolysis (give tranexamic acid)
  • Also helps judge when product resuscitation can stop, and facilitates communication with haematology
  • In one trial, VHA-guided transfusion did not reduce rate of 24hr mortality or massive transfusion, though there was a possible benefit in severe TBI (ITACTIC, 2021)

Local and mechanical measures

  • Direct pressure (at least 10 minutes) and elevation
  • Haemostatic dressings e.g. Celox (chitosan), QuikClot (zeolite); useful for junctional haemorrhage
  • Splinting and traction of long bone fractures
  • Pelvic binder at the level of the greater trochanters, with feet bound together; never 'spring' the pelvis
  • Foley catheter balloon tamponade for penetrating wounds (e.g. neck)
  • REBOA (resuscitative endovascular balloon occlusion of the aorta) in selected centres

Tourniquets

  • For life-threatening limb haemorrhage not controlled by pressure and haemostatic dressings
  • Apply at least 5 cm proximal to the wound but as distal as possible, and document and hand over the time of application
  • A tourniquet in situ is not a stable situation because the limb is ischaemic from the moment it is applied
  • In hospital, reassess the need for it ± replace with a pneumatic tourniquet if still required
  • Surgical haemorrhage control should be achieved within 2 hours; if longer, release for 10 minutes every 2 hours to allow reperfusion

Tranexamic acid

  • An antifibrinolytic that inhibits plasminogen activation
  • Reduced all-cause mortality and death from bleeding in bleeding trauma patients (CRASH-2)
  • It must be given within 3 hours of injury as given later, it was associated with increased mortality from bleeding
  • No increase in thromboembolic events

  • Dose as per trial protocols is 1g IV over 10 minutes, then 1g over 8 hours
  • Many regions have moved to 2g IV stat because it reduces risk of missing the subsequent infusion without increased harm

  • In TBI, early TXA reduced head injury-related death in mild to moderate injury (GCS 9-15) but not overall (CRASH-3)
  • NICE recommends a 2 g IV bolus within 2 hours for moderate or severe TBI

Fibrinogen replacement

  • Fibrinogen falls early and rapidly (consumption and fibrinolysis) and low fibrinogen on arrival is associated with poor outcome
  • Plasma contains around 2 g/L fibrinogen, cryoprecipitate 8-16 g/L and fibrinogen concentrate 20 g/L
  • Early empirical cryoprecipitate did not reduce 28-day mortality (CRYOSTAT-2)

Reversal of anticoagulants

  • Increasingly important with an older trauma population
  • Warfarin: PCC (e.g. 30 IU/kg) plus vitamin K 10 mg IV
  • Heparin: protamine
  • DOACs and antiplatelets: local protocol with haematology input (e.g. idarucizumab for dabigatran)

Vasopressors

  • 'Fill first, then squeeze': hypotension early after injury is haemorrhage until proven otherwise
  • Vasopressors may worsen microcirculatory hypoperfusion and have been associated with worse outcomes
  • They are reasonable once haemorrhage is controlled and other causes excluded, to offset anaesthetic vasodilation, or to maintain CPP in TBI

Recombinant factor VIIa

  • Reduced transfusion in blunt trauma but no mortality benefit, with a risk of thrombosis; it is not licensed for trauma and is no longer routinely recommended
  • Some protocols reserve it for bleeding with no surgical cause once platelets, fibrinogen, temperature, pH and calcium are optimised, after haematology discussion

Cell salvage

  • May be used in theatre, particularly where blood is declined - contamination (e.g. bowel injury) is a relative contraindication

Metabolic

  • Hypocalcaemia: citrate chelates ionised calcium, causing myocardial depression and coagulopathy
  • Hyperkalaemia: potassium leaks from stored red cells; worse with older units and rapid transfusion
  • Acidosis from stored blood and hypoperfusion; later metabolic alkalosis as citrate is metabolised to bicarbonate
  • Hypomagnesaemia
  • Calcium and potassium may need checking every 15 minutes during rapid transfusion

Haematological

  • Dilutional coagulopathy and thrombocytopenia if red cells are given without plasma and platelets
  • Reduced 2,3-DPG in stored blood: left shift of the oxyhaemoglobin dissociation curve
  • Haemolytic transfusion reactions and wrong blood incidents, more likely in emergencies

Other

  • Hypothermia from cold products
  • Volume overload (TACO)
  • Transfusion-related acute lung injury (TRALI) and ARDS, particularly with plasma and platelets
  • Immunomodulation, infection and sepsis
  • Multiple organ failure and increased mortality
  • Air embolism with pressurised infusion

The patient declining blood

  • The patient's wishes must be respected; check for an advance directive
  • Stop bleeding and promote haemostasis: early surgical or IR control, tranexamic acid, normothermia, cell salvage
  • Reduce blood sampling (paediatric bottles) and oxygen consumption
  • Discuss which products may be acceptable, as beliefs vary: platelets, FFP, cryoprecipitate, PCC, fibrinogen concentrate, rFVIIa
  • Promote haemopoiesis with haematology advice (iron, B12, folate, erythropoietin)

Traumatic cardiac arrest

  • Survival is poor, particularly after blunt trauma; the most salvageable causes are tension pneumothorax and cardiac tamponade
  • Treat reversible causes in preference to chest compressions:
    • Haemorrhage control and volume replacement via the major haemorrhage protocol
    • Bilateral thoracostomies
    • Airway and ventilation
  • Resuscitative thoracotomy is indicated for:
    • Penetrating trauma with loss of vital signs <15 minutes previously
    • Blunt trauma with loss of vital signs in the ED and a surgical target (e.g. pericardial collection) on ultrasound
  • Aims of thoracotomy: relieve tamponade, control cardiac wounds, compress or clamp the descending aorta, control hilar haemorrhage
  • Resuscitative laparotomy should not be performed in the ED

Team communication

  • Military-derived tools are now used in civilian practice:
    • Command huddle in the ED (team leader, lead surgeon, lead anaesthetist): CT, theatre or IR next, and which cavity first
    • Snap brief on arrival in theatre: injuries, physiology, products given, coagulopathy and surgical plan
    • Regular situation reports ('sitreps', e.g. every 10 minutes): time elapsed, products given, temperature, gases, coagulation and surgical progress